| Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won, AJ Brown, ... Nature communications 11 (1), 1-14, 2020 | 2160 | 2020 |
| SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14, 2020 | 1504 | 2020 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1473 | 2020 |
| An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice TP Sheahan, AC Sims, S Zhou, RL Graham, AJ Pruijssers, ML Agostini, ... Science translational medicine 12 (541), eabb5883, 2020 | 1089 | 2020 |
| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1080 | 2020 |
| SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo YJ Hou, S Chiba, P Halfmann, C Ehre, M Kuroda, KH Dinnon III, SR Leist, ... Science 370 (6523), 1464-1468, 2020 | 955 | 2020 |
| Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed X Cai, A Schäfer, S Lu, JP Bilello, RC Desrosiers, R Edwards, ... PLoS pathogens 2 (3), e23, 2006 | 704 | 2006 |
| A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures KH Dinnon III, SR Leist, A Schäfer, CE Edwards, DR Martinez, ... Nature 586 (7830), 560-566, 2020 | 665 | 2020 |
| A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ... Cell 183 (1), 169-184. e13, 2020 | 511 | 2020 |
| A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice SR Leist, KH Dinnon, A Schäfer, VT Longping, K Okuda, YJ Hou, A West, ... Cell 183 (4), 1070-1085. e12, 2020 | 505 | 2020 |
| Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice AJ Pruijssers, AS George, A Schäfer, SR Leist, LE Gralinksi, KH Dinnon, ... Cell reports 32 (3), 2020 | 494 | 2020 |
| Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ... Cell 183 (5), 1367-1382. e17, 2020 | 453 | 2020 |
| Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection AL Totura, A Whitmore, S Agnihothram, A Schäfer, MG Katze, MT Heise, ... MBio 6 (3), 10.1128/mbio. 00638-15, 2015 | 424 | 2015 |
| SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 A Wahl, LE Gralinski, CE Johnson, W Yao, M Kovarova, KH Dinnon III, ... Nature 591 (7850), 451-457, 2021 | 390 | 2021 |
| Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... Journal of Experimental Medicine 218 (3), e20201993, 2020 | 310 | 2020 |
| In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies D Li, RJ Edwards, K Manne, DR Martinez, A Schäfer, SM Alam, K Wiehe, ... Cell 184 (16), 4203-4219. e32, 2021 | 297* | 2021 |
| Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor A Schäfer, HP Bogerd, BR Cullen Virology 328 (2), 163-168, 2004 | 286 | 2004 |
| Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif BP Doehle, A Schäfer, BR Cullen Virology 339 (2), 281-288, 2005 | 277 | 2005 |
| Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses VD Menachery, AJ Eisfeld, A Schäfer, L Josset, AC Sims, S Proll, S Fan, ... MBio 5 (3), 10.1128/mbio. 01174-14, 2014 | 265 | 2014 |
| Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors RA Russell, HL Wiegand, MD Moore, A Schäfer, MO McClure, ... Journal of virology 79 (14), 8724-8731, 2005 | 227 | 2005 |
